Ether Glycerophospholipids and Their Potential as Therapeutic Agents
Journal:
Current Organic Chemistry
Volume:
17
Page:
802-811
Author(s):
Su Chen and Chengchu Liu
Editorial (Hot Topic:Therapeutic Agents of Lipids and Fatty Acids)
Journal:
Current Organic Chemistry
Volume:
17
Page:
775-775
Author(s):
Su Chen
Alkylglycerol Lipid Precursors: A Review of Therapeutic Strategies for Plasmalogen Replacement
Journal:
Current Organic Chemistry
Volume:
17
Page:
786-792
Author(s):
Paul L. Wood
Synthesis and Biological Interest of Structured Docosahexaenoic Acid–Containing Triacylglycerols and Phospholipids
Journal:
Current Organic Chemistry
Volume:
17
Page:
841-847
Author(s):
Madeleine Picq, Nathalie Bernoud-Hubac and Michel Lagarde
A New Interpretative Paradigm for Conformational Protein Diseases
Journal:
Current Protein & Peptide Science
Volume:
14
Page:
141-160
Author(s):
Luigi Francesco Agnati, Diego Guidolin, Amina S. Woods, Francisco Ciruela, Chiara Carone, Annamaria Vallelunga, Dasiel Oscar Borroto Escuela, Susanna Genedani and Kjell Fuxe
Harvesting New Therapeutic Avenues with Stem Cell Applications
Journal:
Current Neurovascular Research
Volume:
10
Page:
91-92
Author(s):
Kenneth Maiese
Current Progresses of Novel Natural Products and Their Derivatives/ Analogs as Anti-Alzheimer Candidates: an Update
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
13
Page:
870-887
Author(s):
Lei Fang, Shaohua Gou, Xubin Fang, Lin Cheng and Christian Fleck
Hyperglycemia, Hypoglycemia and Dementia: Role of Mitochondria and Uncoupling Proteins
Journal:
Current Molecular Medicine
Volume:
13
Page:
586-601
Author(s):
S. Cardoso, S.C. Correia, R.X. Santos, C. Carvalho, E. Candeias, A.I. Duarte, A.I. Placido, M.S. Santos and P.I. Moreira
Isoflurane Facilitates Synaptic NMDA Receptor Endocytosis in Mice Primary Neurons
Journal:
Current Molecular Medicine
Volume:
13
Page:
488-498
Author(s):
Y. Dong, X. Wu, G. Zhang, Z. Xu, Y. Zhang, V. Gautam, D.M. Kovacs, A. Wu, Y. Yue and Z. Xie
Lipoxygenase: An Emerging Target for Stroke Therapy
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
12
Page:
191-199
Author(s):
Klaus van Leyen